QantX
  • Home
  • Invest
  • Team
  • Strategy
  • Portfolio
  • News
  • Contact
  • Investor Portal
Select Page
CDotBio

CDotBio

by Harry | Jun 10, 2024

Molydyn

Molydyn

by Harry | Jun 10, 2024

SensefulAI

SensefulAI

by Harry | Jun 10, 2024

Lutra Health

Lutra Health

by Harry | Jun 10, 2024

Test text
Next Entries »

Latest Posts

  • SENISCA: treating age-related diseases with ground-breaking science
  • Lutra Health: integrating community and hospital eyecare
  • QantX leads £600K investment round to speed up innovation in the quantum industry
  • Supporting the Full Innovation Stack: From Lab Discovery to Global Impact
  • QantX partners with the SETsquared Partnership universities on new £300m investment vehicle

enquiries@qantx.co.uk  

Investor Area

QantX (Reference number: 954072) is an Appointed Representative of Kin Capital Partners LLP (FRN: 656789). Kin Capital Partners LLP (trading as Kin Fund Services) is authorised and regulated by the Financial Conduct Authority.

© 2022 QantX. All rights reserved. Cookie Policy | Privacy Policy